The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile

Journal of Pathology

Volumn 214, Issue 5, 2008, Pages 594-602

  Ferracin, M ^a   Gafa R ^a   Miotto, E ^a   Veronese, A ^a   Pultrone, C ^a   Sabbioni, S ^a   Lanza, G ^a   Negrini, M ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

CIMP; Colorectal cancer; Methylator phenotype; Microarray; Microsatellite instability

Indexed keywords

B RAF KINASE; K RAS PROTEIN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 5; NEUROGENIN 1; PROTEIN CACNA1G; PROTEIN RIZ1; SEROTONIN 6 RECEPTOR; SOMATOMEDIN B; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER STAGING; CHROMOSOMAL INSTABILITY; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

AGED; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; CPG ISLANDS; DISEASE-FREE SURVIVAL; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 41649093940     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2318     Document Type: Article

References (14)

1. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-8686.
2. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 2003;4:121-131.
3. Anacleto C, Leopoldino AM, Rossi B, Soares FA, Lopes A, Rocha JC, et al. Colorectal cancer 'methylator phenotype': fact or artifact? Neoplasia 2005;7:331-335.
4. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genet 2006;38:787-793.
5. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-9826.
6. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-845.
7. Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ, et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006;55:1000-1006.
8. Toyota M, Itoh F, Imai K. DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications. J Gastroenterol 2000;35:727-734.
9. Hawkins NJ, Bariol C, Ward RL. The serrated neoplasia pathway. Pathology 2002;34:548-555.
10. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 2004;23:1377- 1391.
11. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007;50:113-130.
12. Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP, Kulke MH, et al. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch 2007;450:529-537.
13. Van Rijnsoever M, Elsaleh H, Joseph D, McCaul K, Iacopetta B. CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Clin Cancer Res 2003;9:2898-2903.
14. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 2005;65:6063-6069.